The haematological response to the immunosuppressive methylhydrazine derivates procarbazine and Ro 4-6824.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D001835:Body Weight; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006834:Hydrazines / Q000009:adverse effects*; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007970:Leukopenia / Q000139:chemically induced; D008221:Lymphoid Tissue / Q000187:drug effects; D008231:Lymphopenia / Q000139:chemically induced; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009504:Neutrophils / Q000187:drug effects; D011344:Procarbazine / Q000627:therapeutic use; D016038:Skin Transplantation; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D001565:Benzoates; D006834:Hydrazines; D007166:Immunosuppressive Agents; D011344:Procarbazine